Acurx Pharmaceuticals, Inc.
corporate_fare Company Profile
Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 21 items for ACXP at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- Acurx Pharmaceuticals Registers Additional 750,000 Shares for Highly Dilutive Lincoln Park Capital Resale Facility
Financial Snapshot
Fiscal year ended December 31, 2025
Net Income
-$7.97M
Diluted EPS
-$5.32
Op. Cash Flow
-$6.79M
Operating Income
-$8.09M
Cash & Equivalents
$7.56M
Debt / Equity
0.00×
Shares Outstanding
2.35M sh
Source: 10-K · filed 2026-03-12 · accession 0001104659-26-027052
show_chartPrice Chart
Loading chart...
feed ACXP - Filings & News (Page 2)
ACXP
Feb 02, 2026, 4:48 PM EST
Price at Filing:
$2.38
Real-time Price:
$1.10
Change:
-$1.28 (-54%)
Market Cap:
$6.3M